Salix Pharmaceuticals

Salix Pharmaceuticals develops drugs and medical devices that prevents and treats various gastrointestinal disorders. Read more

1,139 Followers on Owler
1,139 Followers on Owler
1,139 Followers on Owler
1,139 Followers on Owler

Salix Pharmaceuticals

Salix Pharmaceuticals develops drugs and medical devices that prevents and treats various gastrointestinal disorders. Read more

Robert Spurr's photo - President of Salix Pharmaceuticals

President

Robert Spurr

CEO Approval Rating

82/100

Est. Annual Revenue
Est. Employees
Sector

Update Industry

SALIX PHARMACEUTICALS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Impax Laboratories, Llc is Salix Pharmaceuticals's top competitor. Impax Laboratories, Llc is headquartered in Hayward, California, and was founded in 1995. Impax Laboratories, Llc is in the Pharmaceuticals field. Impax Laboratories, Llc generates 73% the revenue of Salix Pharmaceuticals.

Taro is seen as one of Salix Pharmaceuticals's top competitors. Taro's headquarters is in Hawthorne, New York, and was founded in 1950. Taro competes in the Pharmaceuticals industry. Taro generates 54% of Salix Pharmaceuticals's revenue.

Lannett has been one of Salix Pharmaceuticals's top competitors. Lannett was founded in 1942, and its headquarters is in Trevose, Pennsylvania. Lannett competes in the Pharmaceuticals field. Lannett has 61 more employees than Salix Pharmaceuticals.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 893 a good estimate for Salix Pharmaceuticals's Employee count?

Salix Pharmaceuticals Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Santarus, Inc.

Nov 2013

Source »
$2.6B
Santarus is a biopharmaceutical company, engages in acquiring, developing, and commercializing proprietary products.

-

InKine Pharmaceutical Company

Sep 2012

Source »
$190M
-

These are all the companies that Salix Pharmaceuticals has acquired. Salix Pharmaceuticals has acquired 2 companies and its latest acquisition was Santarus, Inc. in Nov 2013. Santarus is a biopharmaceutical company, engages in acquiring, developing, and commercializing proprietary products.

Salix Pharmaceuticals Funding History

Since Salix Pharmaceuticals was founded in 1989, it has participated in 1 round of funding. In total Salix Pharmaceuticals has raised $60.0M. Salix Pharmaceuticals' funding round was on Aug 2008 for a total of $60.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Aug 2008
$60M
-

Since Salix Pharmaceuticals was founded in 1989, it has participated in 1 round of funding. In total Salix Pharmaceuticals has raised $60.0M. Salix Pharmaceuticals' funding round was on Aug 2008 for a total of $60.0M

Salix Pharmaceuticals Investments

No recent investments found related to Salix Pharmaceuticals

These are all the companies that Salix Pharmaceuticals has invested in. Salix Pharmaceuticals has invested 2 companies and its latest investment was Santarus, Inc. in Nov 2013. Santarus is a biopharmaceutical company, engages in acquiring, developing, and commercializing proprietary products.

Salix Pharmaceuticals News

September 22, 2020The Pharma Letter

Generic challengers settle litigation over Bausch's Xifaxan

Canada-based Bausch Health Companies and its gastroenterology business, Salix Pharmaceuticals, have a... See more »
January 2, 2020firstwordpharma

RedHill Biopharma Regains Rights to its Proprietary Bowel Preparation RHB-106

RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) ("RedHill" or the "Company"), a... See more »
September 4, 2019FiercePharma

Bausch loses Salix president-and turnaround architect-to precision GI company

After four years working to turn around Bausch Health's Salix Pharmaceuticals, President Mark McKenna... See more »
May 17, 20194-traders

Salix Pharmaceuticals Pledges Annual $100,000 Scholarship Program To Outstanding Students Living with GI Disease

(marketscreener.com) BRIDGEWATER, N.J., May 17, 2019 /PRNewswire/ -- Salix Pharmaceuticals ("Salix"),... See more »
April 26, 2019The Pharma Letter

Bausch Health picks up IBD drug amiselimod rejected by Biogen

Bausch Health subsidiary Salix Pharmaceuticals has entered into an exclusive licensing agreement with... See more »
April 25, 2019BioPortfolio

news biotech Salix grabs exAsia rights to Mitsubishi Tanabe autoimmune drug

Biotechnology Pharma and Biopharma News &8211; Research &8211; Science &8211; Lifescience BiotechBiop... See more »

Salix Pharmaceuticals Press Releases

October 22, 2020Cision Canada

Salix To Present Data For Products Across Its Portfolio At The American College Of Gastroenterology 2020 Virtual Annual Meeting

/CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology (GI)... See more »
October 5, 2020PR Newswire

Salix Supports Liver Awareness Month With New Educational Initiatives

Educational Online Resource Offers Tools for Early Detection of Overt Hepatic Encephalopathy in Chron... See more »
September 11, 2020PR Newswire

Salix Presents Two Methylnaltrexone Scientific Posters At PAINWeek 2020

BRIDGEWATER, N.J., Sept. 11, 2020 /PRNewswire/ -- Salix Pharmaceuticals ("Salix"), one of the largest... See more »
June 15, 2020PR Newswire

Salix Announces Inaugural Salix Gastrointestinal Health Scholars Program Recipients

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its gastroenterology business, Salix... See more »
April 30, 2020centralcharts

Salix To Highlight New Data Across Its Portfolio Of Products At Digestive Disease Week 2020 Virtual Meeting

Salix To Highlight New Data Across Its Portfolio Of Products At Digestive Disease Week 2020 Virtual M... See more »
October 31, 2019PR Newswire

Salix Announces Issuance of an Additional XIFAXAN® Patent

LAVAL, Quebec, Oct. 31, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch He... See more »
October 30, 2019centralcharts

Salix Pharmaceuticals Announces Inaugural Scholarship Program To Commemorate Its 30th Anniversary

Salix Pharmaceuticals Announces Inaugural Scholarship Program To Commemorate Its 30th Anniversary PR ... See more »

Social Media

Salix Pharmaceuticals Headquarters

400 Somerset Corporate Boulevard

Bridgewater, New Jersey08807

1-800-321-4576

Driving Directions »

Trending Companies

Salix Pharmaceuticals Summary

ABOUT

Overview

Salix Pharmaceuticals develops drugs and medical devices that prevents and treats various gastrointestinal disorders. Salix Pharmaceuticals was founded in 1989. Salix Pharmaceuticals' headquarters is located in Bridgewater, New Jersey, USA 08807. It h...

CEO

Salix Pharmaceuticals's President, Robert Spurr, currently has an approval rating of 82%. Salix Pharmaceuticals's primary competitors are Impax Laboratories, Llc, Taro & Lannett.

Website

salix.com

Frequently Asked Questions about Salix Pharmaceuticals

  1. When was Salix Pharmaceuticals founded?

    Salix Pharmaceuticals was founded in 1989
  2. Who is Salix Pharmaceuticals's CEO?

    Salix Pharmaceuticals's CEO is Robert Spurr
  3. How much revenue does Salix Pharmaceuticals generate?

    Salix Pharmaceuticals generates $1B in revenue
  4. How much funding does Salix Pharmaceuticals have?

    Salix Pharmaceuticals has historically raised $60M in funding
  1. Where is Salix Pharmaceuticals's headquarters?

    Salix Pharmaceuticals's headquarters is in Bridgewater New Jersey, USA
  2. How many employees does Salix Pharmaceuticals have?

    Salix Pharmaceuticals has 893 employees
  3. Who are Salix Pharmaceuticals's competitors?

    Salix Pharmaceuticals's top competitors are Impax Laboratories, Llc, Taro, Lannett